Martin Investment Management’s AstraZeneca AZN Stock Holding History

Martin Investment Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24M	Sell	126,555 -13,525	-10%	-$2.54M	8.01%	2
2026 Q1	$27.6M	Sell	140,080 -14,674	-9%	-$2.83M	8.27%	1
2025 Q4	$28.5M	Sell	154,754 -5,176	-3%	-$908K	7.96%	2
2025 Q3	$24.5M	Sell	159,930 -1,087	-0.7%	-$165K	6.24%	4
2025 Q2	$22.5M	Buy	161,017 +5,517	+4%	+$773K	5.77%	5
2025 Q1	$22.9M	Buy	155,500 +1,255	+0.8%	+$182K	5.77%	5
2024 Q4	$20.6M	Buy	154,245 +12,143	+9%	+$1.7M	5.65%	8
2024 Q3	$22.6M	Buy	142,102 +3,807	+3%	+$615K	5.53%	6
2024 Q2	$21.6M	Buy	+138,295	New	+$20.8M	5.53%	7

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Martin Investment Management's AZN Position: Q2 2026 in Review

Martin Investment Management reduced its AstraZeneca (AZN) stake by 9.7% in Q2 2026, selling an estimated $2.54M and leaving 126,555 shares worth $24M. The position accounts for 8.01% of the portfolio, ranked #2.

Martin Investment Management first reported a position in AZN in Q2 2024 and has held it in 9 quarters since. The position peaked at $28.5M in Q4 2025. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Martin Investment Management held 126,555 shares of AstraZeneca worth $24M as of Q2 2026.
Martin Investment Management sold 13,525 AstraZeneca shares in Q2 2026, an estimated $2.54M.
AstraZeneca made up 8.01% of Martin Investment Management's portfolio in Q2 2026, its #2 holding.
Martin Investment Management first reported a position in AstraZeneca in Q2 2024 and has held it in 9 quarters since.
Martin Investment Management's AstraZeneca position peaked at $28.5M in Q4 2025.
443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Martin Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.